Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Br J Oral Maxillofac Surg ; 58(5): 508-519, 2020 06.
Artigo em Inglês | MEDLINE | ID: mdl-32143934

RESUMO

The aim of this review was to critically investigate and assess the evidence relating to the use and efficacy of botulinum toxin (BTX) in the management of temporomandibular joint disorders (TMD) and masticatory myofascial pain. A comprehensive search was conducted of PubMed, Scopus, Embase, and Cochrane CENTRAL, to find relevant studies from the last 30 years up to the end of July 2018. Seven were identified. Three showed a significant reduction in pain between the BTX and placebo groups and one showed a clinical, but not a significant, difference. In one that compared BTX with another novel treatment, myofascial pain reduced equally in both groups, and in the remaining two there was no significant difference in pain reduction between the BTX and control groups. Of the four studies that assessed mouth opening, two reported that BTX had resulted in a slight improvement; one reported no improvement, and the other a worsening of the condition. A meta-analysis was not possible because of the considerable variation in the studies' designs, the heterogeneity between the groups, and the different assessment tools used. Despite showing benefits, consensus on the therapeutic benefit of BTX in the management of myofascial TMD is lacking. Further randomised controlled trials with larger sample sizes, minimal bias, and longer follow-up periods are now needed.


Assuntos
Toxinas Botulínicas Tipo A , Síndromes da Dor Miofascial , Fármacos Neuromusculares , Transtornos da Articulação Temporomandibular , Toxinas Botulínicas Tipo A/uso terapêutico , Humanos , Fármacos Neuromusculares/uso terapêutico , Dor , Transtornos da Articulação Temporomandibular/tratamento farmacológico
2.
Aust Dent J ; 62(1): 95-97, 2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-27739083

RESUMO

Although less frequently encountered in dental practices, subcutaneous emphysema of the face and neck has been reported in patients following dental extractions, particularly when lower molar teeth are extracted with the use of a high-speed air-turbine drill designed for restorative treatment, which forces air into the cervical fascial spaces. As facial swelling and pain are the most common presentations, subcutaneous emphysema can often be misdiagnosed as an allergic reaction or odontogenic infection. While usually a benign and self-limiting condition, subcutaneous emphysema may have life-threatening complications such as tension pneumothorax, cardiac tamponade, air embolism, tracheal compression and mediastinitis, which are important to recognize in an emergency setting. Dentists should be aware of the serious risks of inducing subcutaneous emphysema and avoid performing tooth extractions with high-speed air-turbine drills which are specifically designed for use for restorative treatments only.


Assuntos
Dente Molar , Enfisema Subcutâneo/diagnóstico , Extração Dentária/efeitos adversos , Adulto , Equipamentos Odontológicos de Alta Rotação/efeitos adversos , Diagnóstico Diferencial , Face , Feminino , Humanos , Pescoço , Complicações Pós-Operatórias/diagnóstico , Complicações Pós-Operatórias/diagnóstico por imagem , Complicações Pós-Operatórias/etiologia , Enfisema Subcutâneo/diagnóstico por imagem , Enfisema Subcutâneo/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...